News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResApp Health.
RELATED STOCKHEAD STORIES
Health & Biotech
A big RAP: This micro cap biotech jumped 50% on Tuesday while the rest of the market bled out
Tech
Here’s a bunch of weird, cool and wonderful tech stocks on the ASX you probably didn’t know existed
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Health & Biotech
Dr Boreham’s Crucible: A Pfizer takeover could make Resapp a genuine chestbeater
Health & Biotech
5 thematics to bring the Australian life sciences sector back in from the cold
Health & Biotech
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly
News
Closing Bell: Good Friday is coming, let’s hope it makes up for Bad Monday
News
ASX Small Cap Lunch Wrap: Who’s really feeling bullish today?
Health & Biotech
ASX Health Stocks: ResApp skyrockets 25% after getting buyout offer from US giant Pfizer
Experts
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
News
Closing Bell: Shazam for coughing and THIS is how the small cap index surfs the chop – up 10% in a month
News
ASX Small Cap Lunch Wrap: Who’s breaking their silence today?
Health & Biotech
ASX Health Stocks: ResApp jumps 65pc on smartphone Covid-19 cough tests
News
Top 10 at 10: Which ASX stock is king of the pack today?
Health & Biotech
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX
Health & Biotech
ASX Health Stocks: Opthea presents data at global conference; CardieX to progress Philip Morris sponsored study
Health & Biotech
